semaglutide patent novo nordisk Ozempic's problem: how lost control of a blockbuster drug. 💉 Demand for GLP-1 weight-loss drugs has exploded, turning Ozempic into a $40bn+ revenue engine for Novo Nordisk. But, despite Canada approves generic semaglutide from

Monitoring these numbers closely allows health care teams to ensure the treatment is safe and remains on track

Report suspected adverse reactions to B12 supplements via the MHRA Yellow Card Scheme

Greenway, U

When food remains in the stomach longer, there is a higher risk of aspiration, where stomach contents enter the lungs during anesthesia

OL Research supplies the BPC-157 + TB-500 20mg blend a pre-combined 1:1 formulation for multi-pathway research

BOCA RATON, Fla., May 5, 2026 /PRNewswire/ -- MyNetDiary, the top-rated calorie counter and nutrition tracking app with 31 million registered users, today launched GLP-1 Companion within its Premium tier